A Critical Role for P2X7 Receptor-Induced VCAM-1 Shedding and Neutrophil Infiltration during Acute Lung Injury

Area of Science:

• Pulmonary immunology
• Inflammation research
• Innate immunity

Background:

• Pulmonary neutrophils are key in innate immunity but excessive recruitment causes lung injury.
• Pathological neutrophil accumulation exacerbates acute lung injury (ALI).

Purpose of the Study:

• To investigate if soluble VCAM-1 (sVCAM-1) acts as a chemoattractant for neutrophils.
• To determine if sVCAM-1 amplifies lung inflammation in ALI.
• To explore the role of P2X7 receptor in sVCAM-1 mediated lung injury.

Main Methods:

• Utilized a two-hit model of LPS and mechanical ventilation-induced ALI in mice.
• Assessed neutrophil infiltration, lung inflammation, and chemotactic activity.
• Investigated VCAM-1 shedding and signaling via P2X7 receptor and ADAM-17 in lung epithelial cells.
• Employed P2X7 receptor deficiency, inhibitors, and anti-VCAM-1 antibodies.

Main Results:

• sVCAM-1 demonstrated neutrophil chemotactic activity and activated alveolar macrophages.
• Neutralization of sVCAM-1 or P2X7R antagonism reduced neutrophil infiltration and pro-inflammatory cytokines.
• VCAM-1 shedding from epithelial cells was mediated by P2X7 receptor activation of ADAM-17.
• Increased sVCAM-1 ligands were observed during ALI.

Conclusions:

• sVCAM-1 is identified as a novel chemoattractant for neutrophils and an activator of alveolar macrophages.
• Targeting sVCAM-1 offers a potential therapeutic approach to mitigate pathological neutrophil recruitment in ALI.
• This strategy aims to reduce lung inflammation while preserving essential host defense mechanisms.